Posted on 8/9/18
Aldeyra Therapeutics Announces Second Quarter 2018 Financial Results and Provides Corporate Update
Aldeyra Therapeutics, Inc. (NASDAQ: ALDX) (Aldeyra), a biotechnology company devoted to development of next-generation medicines to improve the lives of patients with immune-mediated diseases, today announced . . .
Posted on 8/9/18
New Hampshire Startup Launches the "Siri" of Fitness
If you were asked who would be first to develop a voice-activated fitness platform, you may think Apple, Google, or Amazon. You most likely wouldn't think . . .
Posted on 8/9/18
Momenta Pharmaceuticals Reports Second Quarter 2018 Financial Results and Provides Corporate Update
CAMBRIDGE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq:MNTA) today reported its financial results for the second quarter ended June 30, 2018 and . . .
Posted on 8/9/18
Jounce Therapeutics Reports Second Quarter 2018 Financial Results
CAMBRIDGE, Mass., Aug. 09, 2018 (GLOBE NEWSWIRE) -- Jounce Therapeutics, Inc. (NASDAQ: JNCE), a clinical stage company focused on the discovery and development of novel cancer . . .
Posted on 8/9/18
Charles River Labs: The Growth Is Real
SummaryCharles River Labs reported better-than-expected Q2 2018 results (revenue & earnings) and its management team again raised their full-year guidance.Charles River not only reported impressive operating . . .
Posted on 8/8/18
Verastem Oncology Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
BOSTON--(BUSINESS WIRE)--Verastem, Inc. (Nasdaq:VSTM), focused on developing and commercializing medicines to improve the survival and quality of life of cancer patients, today announced the grant of . . .
Posted on 8/8/18
Spring Bank Announces Proposed Public Offering of Common Stock
HOPKINTON, Mass. and NEW YORK, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Spring Bank Pharmaceuticals, Inc. (Nasdaq: SBPH) today announced that it intends to offer and sell, . . .
Posted on 8/8/18
Sarepta Therapeutics Signs Long-term Strategic Investment and License Agreements with Lacerta Therapeutics
CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Sarepta Therapeutics, Inc. (NASDAQ: SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of precision genetic . . .
Posted on 8/8/18
Ziopharm Oncology Reports Q2 2018 Financial Results and Provides Corporate Update
BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Ziopharm Oncology, Inc. (Nasdaq:ZIOP), today announced financial results for the second quarter ended June 30, 2018, and provided an . . .
Posted on 8/8/18
Collegium Reports Q2 Financial Results and Provides Corporate Update
CANTON, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (Nasdaq: COLL) today reported its financial results for the second quarter of 2018 and provided . . .
Posted on 8/8/18
Corbus Pharmaceuticals Reports 2018 Q2 Financial Results and Provides Business Update
Norwood, MA, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP), a Phase 3 clinical-stage pharmaceutical company focused on the development and commercialization . . .
Posted on 8/8/18
Recovery Centers of America-Danvers Partners with Square Medical Group
Recovery Centers of America (RCA), a neighborhood-based addiction treatment provider delivering individualized, evidence-based care, announced today that the Danvers, Mass., facility has partnered with Square Medical . . .
Posted on 8/8/18
SQZ Biotech Completes $72 Million Series C Financing
SQZ Biotechnologies (SQZ), a cell therapy company developing novel treatments for multiple therapeutic areas, announced the completion of an oversubscribed $72 million Series C
Posted on 8/8/18
XebiaLabs Recognized by Independent Research Firm in Value Stream Management Report
BOSTON--(BUSINESS WIRE)--XebiaLabs, the recognized leader in Enterprise DevOps and Continuous Delivery software, today announced that it has been named a Strong Performer in the newly released . . .
Posted on 8/8/18
Lumicell Launches Wound Care Infection and Perfusion Division
WELLESLEY, Mass.--(BUSINESS WIRE)--Lumicell, Inc., a leader in the field of image-guided cancer surgery, today announced that it has created a new division to drive the expansion . . .
Posted on 8/8/18
Keryx Biopharmaceuticals Announces Second Quarter 2018 Financial Results
BOSTON, Aug. 08, 2018 (GLOBE NEWSWIRE) -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX), a biopharmaceutical company focused on bringing innovative medicines to people with kidney disease, today . . .
Posted on 8/8/18
Leap Therapeutics Reports Second Quarter 2018 Business Update and Financial Results
CAMBRIDGE, Mass., Aug. 08, 2018 (GLOBE NEWSWIRE) -- Leap Therapeutics, Inc. (Nasdaq:LPTX), a biotechnology company developing targeted and immuno-oncology therapeutics, today reported a business update and . . .
Posted on 8/8/18
Boston Scientific To Acquire VENITI $160M
Boston Scientific (NYSE:BSX) has agreed to acquire privately held VENITI, the maker of the VICI VENOUS STENT System for treating venous obstructive disease. BSX has owned . . .
Posted on 8/8/18
Biogen Hits A Potential Home Run
SummaryBiogen's current product lineup is beginning to show its age, and a fresh injection of novel products may be necessary to jumpstart top-line revenue growth.Spinraza is . . .
Posted on 8/8/18
Buy Biogen For Alzheimer's Therapy Pipeline
SummarySome possible Alzheimer's success is now built into the stock price.Disputes about Alzheimer's trial details are muddying the picture.Three candidates with good Phase 2 data means . . .
Posted on 8/7/18
Infinity Pharmaceuticals Provides Company Update and Q2 2018 Financial Results
Infinity Pharmaceuticals, Inc. (NASDAQ: INFI) today announced its second quarter 2018 financial results and provided an update on the company, including its progress with IPI-549, a . . .
Posted on 8/7/18
Syndax Pharmaceuticals Reports Q2 2018 Financial Results and Provides Clinical and Business Update
Syndax Pharmaceuticals, Inc. (Nasdaq: SNDX), a clinical stage biopharmaceutical company developing an innovative pipeline of cancer therapies, today reported its financial results for the second quarter ended . . .
Posted on 8/7/18
AVEO Reports Q2 2018 Financial Results and Provides Business Update
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Oncology (NASDAQ:AVEO) today reported financial results for the second quarter ended June 30, 2018 and provided a business update.“Our U.S. registration strategy remains . . .
Posted on 8/7/18
InVivo Therapeutics Reports 2018 Second Quarter Financial Results
CAMBRIDGE, Mass.--(BUSINESS WIRE)--InVivo Therapeutics Holdings Corp. (NVIV) today provided a business update and reported financial results for the quarter ended June 30, 2018.Richard Toselli, M.D., President . . .
Posted on 8/7/18
Eloxx Pharmaceuticals Reports Q2 2018 Financial and Operating Results and Provides Business Update
WALTHAM, Mass., Aug. 07, 2018 (GLOBE NEWSWIRE) -- Eloxx Pharmaceuticals, Inc., (NASDAQ: ELOX) a clinical-stage biopharmaceutical company dedicated to the discovery and development of novel therapeutics . . .

